{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:13:42Z","timestamp":1770819222669,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1124\/dmd.113.056622","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T02:28:51Z","timestamp":1394677731000},"page":"963-973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Paradoxical Attenuation of Autoimmune Hepatitis by Oral Isoniazid in Wild-Type and N-Acetyltransferase\u2013Deficient Mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Imir G.","family":"Metushi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libia","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis M.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Uetrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.056622_bib1","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.4049\/jimmunol.181.6.3733","article-title":"Macrophage polarization in bacterial infections","volume":"181","author":"Benoit","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/dmd.113.056622_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Isoniazid-associated hepatitis in 114 patients","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.113.056622_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhep.2006.01.027","article-title":"Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice","volume":"45","author":"Chowdhury","year":"2006","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.113.056622_bib4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/dmd.113.056622_bib5","first-page":"22","article-title":"Population-based toxicity assessment implicates mitochondrial dysfunction as an early event in isoniazid-induced liver injury","volume":"126","author":"Eaddy","year":"2012","journal-title":"The Toxicologist (Supplement to Toxicological Sciences)"},{"key":"10.1124\/dmd.113.056622_bib6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2009.09.012","article-title":"Alternatively activated macrophages in infection and autoimmunity","volume":"33","author":"Fairweather","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1124\/dmd.113.056622_bib7","first-page":"596A","article-title":"Profiles of leukocytes infiltrating livers of subjects with drug-induced liver injury (DILI)","volume":"56","author":"Foureau","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.056622_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2131\/jts.33.187","article-title":"Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients","volume":"33","author":"Fukino","year":"2008","journal-title":"J Toxicol Sci"},{"key":"10.1124\/dmd.113.056622_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.056622_bib10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/tx900086v","article-title":"Macrophages and inflammatory mediators in chemical toxicity: a battle of forces","volume":"22","author":"Laskin","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.113.056622_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.056622_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-79-1-1","article-title":"Isoniazid hepatitis","volume":"79","author":"Maddrey","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.113.056622_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.41.4.534","article-title":"Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury","volume":"41","author":"Maria","year":"1997","journal-title":"Gut"},{"key":"10.1124\/dmd.113.056622_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.taap.2012.08.015","article-title":"Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity","volume":"264","author":"McGill","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.113.056622_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/clpt.2010.355","article-title":"A fresh look at the mechanism of isoniazid-induced hepatotoxicity","volume":"89","author":"Metushi","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.056622_bib16","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/tx300341r","article-title":"Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats","volume":"25","author":"Metushi","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.113.056622_bib17","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26564","article-title":"Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure","volume":"P59","author":"Metushi","year":"2014","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.056622_bib18","doi-asserted-by":"crossref","unstructured":"Metushi IG and Uetrecht J (2013) Isoniazid-induced liver injury and immune response in mice. J Immunotoxicol DOI: 10.3109\/1547691X.2013.860644","DOI":"10.3109\/1547691X.2013.860644"},{"key":"10.1124\/dmd.113.056622_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-013-1864-7","article-title":"Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin","volume":"387","author":"Metushi","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/dmd.113.056622_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.68.2.181","article-title":"Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy","volume":"68","author":"Mitchell","year":"1975","journal-title":"Chest"},{"key":"10.1124\/dmd.113.056622_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-84-2-181","article-title":"Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis","volume":"84","author":"Mitchell","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.113.056622_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0006-2952(96)00468-6","article-title":"Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450","volume":"52","author":"Monshouwer","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.056622_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1126\/science.7838","article-title":"Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat","volume":"193","author":"Nelson","year":"1976","journal-title":"Science"},{"key":"10.1124\/dmd.113.056622_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yexmp.2004.10.004","article-title":"A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB\/c mouse","volume":"78","author":"Njoku","year":"2005","journal-title":"Exp Mol Pathol"},{"key":"10.1124\/dmd.113.056622_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1258\/002367702320162414","article-title":"Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats","volume":"36","author":"O\u2019Brien","year":"2002","journal-title":"Lab Anim"},{"key":"10.1124\/dmd.113.056622_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0016-5085(77)80088-7","article-title":"Isoniazid-rifampin fulminant hepatitis: a possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction","volume":"72","author":"Pessayre","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.113.056622_bib26","first-page":"298","article-title":"[Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients]","volume":"39","author":"Pilheu","year":"1979","journal-title":"Medicina (B Aires)"},{"key":"10.1124\/dmd.113.056622_bib27","first-page":"439","article-title":"[Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid]","volume":"41","author":"Pilheu","year":"1981","journal-title":"Medicina (B Aires)"},{"key":"10.1124\/dmd.113.056622_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11095-004-9010-6","article-title":"Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain","volume":"22","author":"Projean","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.113.056622_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ni.1894","article-title":"Programming dendritic cells to induce T(H)2 and tolerogenic responses","volume":"11","author":"Pulendran","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1124\/dmd.113.056622_bib30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.51.9.1085","article-title":"Systemic lupus erythematosus induced by isoniazid","volume":"51","author":"Salazar-P\u00e1ramo","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/dmd.113.056622_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002040050347","article-title":"Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits","volume":"70","author":"Sarich","year":"1996","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.113.056622_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.056622_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/01480549709003881","article-title":"Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats","volume":"20","author":"Sodhi","year":"1997","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/dmd.113.056622_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.64.1.170","article-title":"Generation and functional characterization of arylamine N-acetyltransferase Nat1\/Nat2 double-knockout mice","volume":"64","author":"Sugamori","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.056622_bib35","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1530-0277.2010.01309.x","article-title":"Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites","volume":"34","author":"Thiele","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/dmd.113.056622_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)32069-0","article-title":"Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo","volume":"213","author":"Timbrell","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.056622_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2222.1982.tb02521.x","article-title":"The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis","volume":"12","author":"Warrington","year":"1982","journal-title":"Clin Allergy"},{"key":"10.1124\/dmd.113.056622_bib38","first-page":"97","article-title":"Evaluation of isoniazid-associated hepatitis by immunological tests","volume":"32","author":"Warrington","year":"1978","journal-title":"Clin Exp Immunol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624114195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624114195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.056622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:34:34Z","timestamp":1739907274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624114195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090955624114195"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.056622","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical Attenuation of Autoimmune Hepatitis by Oral Isoniazid in Wild-Type and N-Acetyltransferase\u2013Deficient Mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.056622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}